Notice2022-05810
Foreign-Trade Zone (FTZ) 43-Battle Creek, Michigan; Notification of Proposed Production Activity; Pfizer, Inc. (Lipid Active Pharmaceutical Ingredients), Kalamazoo, Michigan
Primary source
Metadata and text below are from the Federal Register, a public-domain U.S. government work. Always verify the official published version before relying on it for any legal matter.
Published
March 21, 2022
Issuing agencies
Commerce DepartmentForeign-Trade Zones Board
Full Text
<html>
<head>
<title>Federal Register, Volume 87 Issue 54 (Monday, March 21, 2022)</title>
</head>
<body><pre>
[Federal Register Volume 87, Number 54 (Monday, March 21, 2022)]
[Notices]
[Page 15911]
From the Federal Register Online via the Government Publishing Office [<a href="http://www.gpo.gov">www.gpo.gov</a>]
[FR Doc No: 2022-05810]
-----------------------------------------------------------------------
DEPARTMENT OF COMMERCE
Foreign-Trade Zones Board
[B-8-2022]
Foreign-Trade Zone (FTZ) 43--Battle Creek, Michigan; Notification
of Proposed Production Activity; Pfizer, Inc. (Lipid Active
Pharmaceutical Ingredients), Kalamazoo, Michigan
Pfizer, Inc. (Pfizer) submitted a notification of proposed
production activity to the FTZ Board (the Board) for its facility in
Kalamazoo, Michigan within Subzone 43E. The notification conforming to
the requirements of the Board's regulations (15 CFR 400.22) was
received on March 11, 2022.
Pursuant to 15 CFR 400.14(b), FTZ production activity would be
limited to the specific foreign-status materials/components and
specific finished products described in the submitted notification
(summarized below) and subsequently authorized by the Board. The
benefits that may stem from conducting production activity under FTZ
procedures are explained in the background section of the Board's
website--accessible via <a href="http://www.trade.gov/ftz">www.trade.gov/ftz</a>. The proposed finished
products and materials/components would be added to the production
authority that the Board previously approved for the operation, as
reflected on the Board's website.
The proposed finished products include active pharmaceutical
ingredients for Pfizer's COVID-19 vaccine--Lipid ALC-0159 K Finished
and Lipid ALC-0315 Crude (duty rate is 3.7% or 6.5%).
The proposed foreign-status materials and components include:
Methoxy Polyethylene Glycol (MPEG) Acid; Enzyme CDX-616; Registered
Starter Chemical PF-07321332; 2,2,6,6-Tetramethylpiperidine-1-Oxyl; 1-
Propanephosphonic Acid Cyclic Andydrid; 4-Amino-1-Butanol; Tetamine NS
Succinate Salt; and, 2-Hexyldecanoic Acid (duty rate ranges from duty
free to 6.5%). The request indicates that certain materials/components
are subject to duties under Section 301 of the Trade Act of 1974
(Section 301), depending on the country of origin. The applicable
Section 301 decisions require subject merchandise to be admitted to
FTZs in privileged foreign status (19 CFR 146.41).
Public comment is invited from interested parties. Submissions
shall be addressed to the Board's Executive Secretary and sent to:
<a href="/cdn-cgi/l/email-protection#8bedfff1cbfff9eaefeea5ece4fd"><span class="__cf_email__" data-cfemail="d5b3a1af95a1a7b4b1b0fbb2baa3">[email protected]</span></a>. The closing period for their receipt is May 2, 2022.
A copy of the notification will be available for public inspection
in the ``Online FTZ Information System'' section of the Board's
website.
For further information, contact Diane Finver at
<a href="/cdn-cgi/l/email-protection#56123f37383378103f3820332416222437323378313920"><span class="__cf_email__" data-cfemail="bcf8d5ddd2d992fad5d2cad9cefcc8ceddd8d992dbd3ca">[email protected]</span></a>.
Dated: March 15, 2022.
Andrew McGilvray,
Executive Secretary.
[FR Doc. 2022-05810 Filed 3-18-22; 8:45 am]
BILLING CODE 3510-DS-P
</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>Indexed from Federal Register on March 21, 2022.
This is legal information, not legal advice. Laws vary by jurisdiction and change frequently. Always verify current law with official sources and consult a licensed attorney in your jurisdiction for advice on your specific situation.